Shah Pratik
SEC insider (Form 3/4/5 filer). CIK 0001580787. Director at ARS Pharmaceuticals, Inc. (SPRY) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in SAN DIEGO, CA.
Companies Shah Pratik has filed insider reports for
- ARS Pharmaceuticals, Inc. (SPRY): Director
- Design Therapeutics, Inc. (DSGN): Director, Officer, President, CEO and Chairperson
Shah Pratik
CIK: 0001580787
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 24, 2026SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
30K shares- - Jan 2, 2026DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
750K shares- - Dec 9, 2025DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
525K shares- - Dec 9, 2025DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
525K shares- - Nov 12, 2025SPRY
ARS Pharmaceuticals, Inc.
GiftIndirect250K shares- - Nov 12, 2025SPRY
ARS Pharmaceuticals, Inc.
GiftIndirect100K shares- - Jun 25, 2025SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
30K shares- - Jan 2, 2025DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
600K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  SPRY ARS Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jan 2, 2026 |  DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 750,000 | - | - | Direct |
| Dec 9, 2025 | DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 525,000 | - | - | Direct |
| Dec 9, 2025 | DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 525,000 | - | - | Direct |
| Nov 12, 2025 | SPRY ARS Pharmaceuticals, Inc. | Gift | 250,000 | - | - | Indirect |
| Nov 12, 2025 | SPRY ARS Pharmaceuticals, Inc. | Gift | 100,000 | - | - | Indirect |
| Jun 25, 2025 | SPRY ARS Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jan 2, 2025 | DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 600,000 | - | - | Direct |
1-8 of 8 transactions